NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma Article

Tsien, Christina I, Pugh, Stephanie L, Dicker, Adam P et al. (2023). NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma . JOURNAL OF CLINICAL ONCOLOGY, 41(6), 1285-+. 10.1200/JCO.22.00164

Open Access ESI Most Cited Paper

cited authors

  • Tsien, Christina I; Pugh, Stephanie L; Dicker, Adam P; Raizer, Jeffrey J; Matuszak, Martha M; Lallana, Enrico C; Huang, Jiayi; Algan, Ozer; Deb, Nimisha; Portelance, Lorraine; Villano, John L; Hamm, John T; Oh, Kevin S; Ali, Arif N; Kim, Michelle M; Lindhorst, Scott M; Mehta, Minesh P

sustainable development goals

authors

publication date

  • February 20, 2023

published in

keywords

  • COMBINATION
  • HIGH-GRADE GLIOMA
  • HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • Oncology
  • PLUS IRINOTECAN
  • QUALITY-OF-LIFE
  • RADIATION-THERAPY
  • RADIOSURGERY
  • SINGLE-AGENT BEVACIZUMAB
  • Science & Technology
  • TUMOR PROGRESSION

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 1285

end page

  • +

volume

  • 41

issue

  • 6